These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26081748)

  • 1. Heterogeneity in the prognosis of major depression: from the common cold to a highly debilitating and recurrent illness.
    Lorenzo-Luaces L
    Epidemiol Psychiatr Sci; 2015 Dec; 24(6):466-72. PubMed ID: 26081748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.
    Glassman AH; Bigger JT; Gaffney M; Shapiro PA; Swenson JR
    Arch Gen Psychiatry; 2006 Mar; 63(3):283-8. PubMed ID: 16520433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing major depressive disorder IV: relationship between number of symptoms and the diagnosis of disorder.
    Zimmerman M; McGlinchey JB; Young D; Chelminski I
    J Nerv Ment Dis; 2006 Jun; 194(6):450-3. PubMed ID: 16772864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD.
    Kornstein SG; Gommoll C; Chen C; Kramer K
    J Affect Disord; 2016 Mar; 193():137-43. PubMed ID: 26773906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of single episode and recurrent major depressive disorder among smokers in cessation treatment: Associations with depressive symptomatology and early cessation failure.
    Cohn AM; Strong DR; Abrantes AM; Brown RA
    Addict Disord Their Treat; 2010 Mar; 9(1):41-52. PubMed ID: 20228875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The difference between depression and melancholia: two distinct conditions that were combined into a single category in DSM-III].
    Ohmae S
    Seishin Shinkeigaku Zasshi; 2012; 114(8):886-905. PubMed ID: 23012851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.
    McIntyre RS; Soczynska JK; Cha DS; Woldeyohannes HO; Dale RS; Alsuwaidan MT; Gallaugher LA; Mansur RB; Muzina DJ; Carvalho A; Kennedy SH
    J Affect Disord; 2015 Feb; 172():259-64. PubMed ID: 25451425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-episode mood lability in mood disorders: residual symptom or natural course of illness?
    Benazzi F
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):480-6. PubMed ID: 15482578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric MRI study of the habenula in first episode, recurrent and chronic major depression.
    Carceller-Sindreu M; de Diego-Adeliño J; Serra-Blasco M; Vives-Gilabert Y; Martín-Blanco A; Puigdemont D; Álvarez E; Pérez V; Portella MJ
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2015-21. PubMed ID: 26404405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression.
    Wu B; Cai Q; Sheehan JJ; Benson C; Connolly N; Alphs L
    PLoS One; 2019; 14(8):e0220763. PubMed ID: 31393922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in 10-Year Course Trajectories of Moderate to Severe Major Depressive Disorder: A Danish National Register-Based Study.
    Musliner KL; Munk-Olsen T; Laursen TM; Eaton WW; Zandi PP; Mortensen PB
    JAMA Psychiatry; 2016 Apr; 73(4):346-53. PubMed ID: 26934026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.